Know Cancer

forgot password

Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by PROTEOMEX

Phase 1
18 Years
90 Years
Open (Enrolling)
Hepatocellular Carcinoma

Thank you

Trial Information

Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by PROTEOMEX

Cell lines Hep3B and Huh7 HCC cell lines will be cultured in (Dulbecco’s modified Eagle
medium) DMEM containing 10% fetal calf serum and incubated at 37 C in 5% CO2 incubator. The
rationale of using HCC cell line instead of clinical HCC samples is that HCC tissues are
heterogeneous and might contain some non-HCC cells. The cell will be harvested when cells
reach 95% confluence.

Sera collection 20 mL of venous 20 mL of venous blood was collected from 20 HBV-related HCC
and 20 HCV-related HCC patients before treatment. The venous blood was allowed to clot,
centrifuged at 800 g for 5 min, and serum was aliquoted and stored at –80 0C. Control sera
were obtained from 20 HBV carriers without HCC, 20 chronic hepatitis C patients without HCC,
and 10 normal subjects without liver diseases.

Two-dimensional gel electrophoresis using patients' sera for immunoblotting will be done.
Spots of interest will be identified by delayed extraction matrix-assisted laser desorption

Inclusion Criteria:

- hepatocellular carcinoma

Exclusion Criteria:

- multiple cancers

Type of Study:


Study Design:

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional, Time Perspective: Retrospective/Prospective

Principal Investigator

Chien-Hung Chen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Taiwan University Hospital


Taiwan: Department of Health

Study ID:




Start Date:

August 2004

Completion Date:

Related Keywords:

  • Hepatocellular Carcinoma
  • Carcinoma
  • Carcinoma, Hepatocellular